Skip to main content
. 2019 Nov 6;5(2):165–172. doi: 10.1016/j.ekir.2019.10.012

Table 1.

Data of the 4 groups of enrolled patients and healthy volunteers

Secondary IgA nephropathy IgA nephropathy Nephropathy control Healthy control
No. of participants 100 32 41 39
Age (yr) 45.67 ± 14.56 37.88 ± 11.16 39.8 ± 17.56 34.95 ± 8.69
Sex (male/female) 59/41 19/13 18/23 17/22
Proteinuria (g/d) 2.65 2.97 5.26
SBP (mm Hg) 131 ± 18 131 ± 11 132 ± 17
DBP (mm Hg) 81 ± 13 83 ± 9 84 ± 14
MAP (mm Hg) 98 ± 14 99 ± 9 100 ± 14
SCr (mmol/l) 158 ± 150 240 ± 227 191 ± 229
eGFR (ml/min per 1.73 m2) 64.9 ± 35 49.3 ± 33.8 71 ± 43
Serum IgA (g/l) 4.27 ± 1.60 3.30 ± 1.14 1.92 ± 0.89
Serum IgG (g/l) 11.92 ± 5.21 9.96 ± 2.61 9.77 ± 6.45
Serum C3 (g/l) 0.98 ± 0.27 0.87 ± 0.18 0.83 ± 0.47
Serum C4 (g/l) 0.28 ± 0.35 0.21 ± 0.05 0.19 ± 0.13

DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; MAP, mean arterial pressure; SBP, systolic blood pressure; SCr, serum creatinine.